Literature DB >> 22678739

Severe Crimean-Congo haemorrhagic fever presented with massive retroperitoneal haemorrhage that recovered without antiviral treatment.

Mehrnaz Asadi Gharabaghi1, Sadegh Chinikar, Seyyed Mojtaba Ghiasi, Maryam Morady, Taha Ahmadinejhad, Koosha Paydary.   

Abstract

Crimean-Congo haemorrhagic fever (CCHF) is a tickborne viral zoonosis with up to 50% mortality in humans caused by CCHF virus belonging to the genus Nairovirus, family Bunyaviridae. The geographical distribution of CCHF cases corresponds closely with the distribution of principle tick vectors that is species of Hyaloma. The disease presents with non-specific febrile symptoms, but progress to a serious haemorrhagic syndrome that, soon after, a full blown multi organ failure may develop with prominent features of liver damage and bleeding diathesis. The authors present a case of a 39-year-old man with severe CCHF with retroperitoneal haemorrhage that recovered without ribavirin administration. The case was confirmed for CCHF by serological and molecular tests.

Entities:  

Mesh:

Year:  2011        PMID: 22678739      PMCID: PMC3171037          DOI: 10.1136/bcr.10.2010.3408

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  29 in total

Review 1.  The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa.

Authors:  H Hoogstraal
Journal:  J Med Entomol       Date:  1979-05-22       Impact factor: 2.278

2.  Characteristics of Crimean-Congo hemorrhagic fever virus (Xinjiang strain) in China.

Authors:  Y C Yen; L X Kong; L Lee; Y Q Zhang; F Li; B J Cai; S Y Gao
Journal:  Am J Trop Med Hyg       Date:  1985-11       Impact factor: 2.345

3.  Detection of human antibodies to Crimean-Congo haemorrhagic fever virus using expressed viral nucleocapsid protein.

Authors:  A C Marriott; T Polyzoni; A Antoniadis; P A Nuttall
Journal:  J Gen Virol       Date:  1994-09       Impact factor: 3.891

4.  A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part I. Clinical features.

Authors:  P J van Eeden; J R Joubert; B W van de Wal; J B King; A de Kock; J H Groenewald
Journal:  S Afr Med J       Date:  1985-11-09

5.  Genetic analysis of Crimean-congo hemorrhagic fever virus in Iran.

Authors:  Sadegh Chinikar; Stine-Mari Persson; Marie Johansson; Linda Bladh; Mehdi Goya; Badakhshan Houshmand; Ali Mirazimi; Alexander Plyusnin; Ake Lundkvist; Mikael Nilsson
Journal:  J Med Virol       Date:  2004-07       Impact factor: 2.327

6.  The clinical pathology of Crimean-Congo hemorrhagic fever.

Authors:  R Swanepoel; D E Gill; A J Shepherd; P A Leman; J H Mynhardt; S Harvey
Journal:  Rev Infect Dis       Date:  1989 May-Jun

7.  A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part III. Clinical pathology and pathogenesis.

Authors:  J R Joubert; J B King; D J Rossouw; R Cooper
Journal:  S Afr Med J       Date:  1985-11-09

8.  Crimean Congo-haemorrhagic fever treated with oral ribavirin.

Authors:  S P Fisher-Hoch; J A Khan; S Rehman; S Mirza; M Khurshid; J B McCormick
Journal:  Lancet       Date:  1995-08-19       Impact factor: 79.321

Review 9.  [Crimean-Congo hemorrhagic fever in Senegal. Latest data on the ecology of the CCHF virus].

Authors:  J L Camicas; J P Cornet; J P Gonzalez; M L Wilson; F Adam; H G Zeller
Journal:  Bull Soc Pathol Exot       Date:  1994

10.  Clinical features of Crimean-Congo haemorrhagic fever in the United Arab Emirates.

Authors:  T F Schwarz; H Nsanze; A M Ameen
Journal:  Infection       Date:  1997 Nov-Dec       Impact factor: 7.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.